Research Output per year
Background Artemisinin-based combination therapy (ACT) is the recommended treatment against uncomplicated Plasmodium falciparum infections, and ACT is widely used. It has been shown that gametocytes may be present after ACT and transmission to mosquitoes is still possible. Artemether–lumefantrine (AL) is a broadly used artemisinin-based combination medicine. Here, it is tested whether AL influences behaviour and fitness of Anopheles mosquitoes, which are the main vectors of P. falciparum. Results Dual-choice olfactometer and screenhouse experiments showed that skin odour of healthy human individuals obtained before, during and after AL-administration was equally attractive to Anopheles coluzzii and Anopheles gambiae sensu stricto, apart from a small (but significant) increase in mosquito response to skin odour collected 3 weeks after AL-administration. Anopheles coluzzii females fed on parasite-free blood supplemented with AL or on control-blood had similar survival, time until oviposition and number of eggs produced. Conclusions Based on the results, AL does not appear to influence malaria transmission through modification of vector mosquito olfactory behaviour or fitness. Extending these studies to Plasmodium-infected individuals and malaria mosquitoes with parasites are needed to further support this conclusion.
|Date made available||28 Jan 2019|
28 Jan 2019, In : Malaria Journal. 18, 28.
Research output: Contribution to journal › Article › Academic › peer-review
de Boer, J. G. (Creator), Busula, A. O. (Creator), ten Berge, J. (Creator), van Dijk, T. S. (Creator), Takken, W. (Creator) (28 Jan 2019). Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?10.6084/m9.figshare.c.4381640